RJFSA
EDSA icon

Raymond James Financial Services Advisors’s Edesa Biotech EDSA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-359
Closed -$21K – 2616
2018
Q3 		$21K Hold
359
– – ﹤0.01% 2763
2018
Q2 		$27K Buy
+359
New +$51.4K ﹤0.01% 2705

Other funds holding EDSA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Raymond James Financial Services Advisors's EDSA Position: Q4 2018 in Review

Raymond James Financial Services Advisors sold out of Edesa Biotech (EDSA) in Q4 2018, closing a stake of 359 shares — an estimated $21K sold.

Raymond James Financial Services Advisors first reported a position in EDSA in Q2 2018 and held it in 2 quarters. The position peaked at $27K in Q2 2018. 10 funds tracked by Wall St. Rank hold EDSA as of Q4 2018.

  • Raymond James Financial Services Advisors reported no remaining Edesa Biotech position as of Q4 2018 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 359 Edesa Biotech shares in Q4 2018, an estimated $21K.
  • Raymond James Financial Services Advisors first reported a position in Edesa Biotech in Q2 2018 and held it in 2 quarters.
  • Raymond James Financial Services Advisors's Edesa Biotech position peaked at $27K in Q2 2018.
  • 10 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.